A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319134A Genes of 1-desoxy-D-xylulose biosynthetic pathway
10/24/2001	CN1319101A Tetrahydropyridoethers
10/24/2001	CN1319100A Isoquinoline derivatives with angiogenesis inhibiting activity
10/24/2001	CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines
10/24/2001	CN1319096A Quinazoline derivatives and pharmaceutical applications thereof
10/24/2001	CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1319090A Novel substuted indolimones, their preparation process and use as medicine
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319083A 5,6-Dihydronaphthalenyl derivatives haivng retionoid-like activity
10/24/2001	CN1319016A Process for preparation of oral pharmaceutical compositions comprising biphosphonates
10/24/2001	CN1319015A Compositions containing diphosphonic acids
10/24/2001	CN1319014A Use of benzenesulfonyl (thio) ureas for treatment and prophylaxis of dysfunctions of autonomous nervous system and use of benzenesulfonyl(thio) ureas in combination with beta-receptor blockers
10/24/2001	CN1319013A Pharmaceutical agents for treatment of parkinson's diseae, ADHD and microadenomas
10/24/2001	CN1319012A Method for treating diabetes employing ap2 inhibitor and combination
10/24/2001	CN1319011A Tumor tissue accumulation enhancers for drugs
10/24/2001	CN1319010A Treatment regimen for administration of phenylacetylgluta-mine, phenylacetylisoglutamize, and/or phenylacetate
10/24/2001	CN1319009A Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/24/2001	CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001	CN1319006A Use of organophosphorous compounds for producing medicaments for therapeutic and prophylactic treatment of infections or as fungicide, bactericide or herbicide for plants
10/24/2001	CN1319005A Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative
10/24/2001	CN1319004A New pharmaceutical formulation
10/24/2001	CN1318645A Liver cancer related gene and its application
10/24/2001	CN1318569A Febuprol cyclodextrin clathrate and its preparation
10/24/2001	CN1318552A New actin and polynucleotide sequence for encoding it
10/24/2001	CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/24/2001	CN1318541A Sulfonyl pyrrolidone containing compound and its preparation and pharmaceutical application
10/24/2001	CN1318392A Beriberi treating ointment
10/24/2001	CN1318387A Wound-treating external-use medicine
10/24/2001	CN1318382A Nutrient agent and its application
10/24/2001	CN1318373A Application of Breviscapine in preparing medicine
10/24/2001	CN1318372A Application of insulin sensitizing agent in treatment of nephrosis
10/24/2001	CN1318371A New use of flavone
10/24/2001	CN1318370A Application of fumaric acid in preparing medicine
10/24/2001	CN1318317A Weight-reducing and blood lipoid reducing health food
10/24/2001	CN1073573C Low-toxicity antiphlogistic exudation-resisting medicine composition
10/24/2001	CN1073565C New 3-(piperid-4-yl)-1,2-benzisoxazole and 3-(piperazin-4-yl)-1,2-benzisoxazole compounds, processes for their preparation
10/24/2001	CN1073562C Method for extracting material containing raw anthocyanidin from ginkgo leaf by supercritical carbon dioxide
10/24/2001	CN1073557C Vitamin-D amide derivatives
10/24/2001	CN1073552C Benzamides for neurodegenerative disorder treatment
10/24/2001	CN1073441C Broad-spectrum antibacterial medicine
10/24/2001	CN1073435C Infantile cough plaster and its production method
10/24/2001	CN1073422C Use of progestin for preparing medicine for reducing endometrorrhagia
10/24/2001	CN1073421C Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta adrenergic antagonist
10/24/2001	CN1073420C Vermifuge composition for farm animal
10/24/2001	CN1073419C Compound eye drops for preventing and treating eye infection and its preparation
10/24/2001	CN1073418C Interleukin-8 production inhibitor
10/24/2001	CN1073417C Ankang capsule for abstaining from drugs
10/24/2001	CN1073416C New use of caffeic acid and ferulic acid antagonistic endotheliolysin biological effect
10/24/2001	CN1073415C Application of sulfamides compound in preparation of anticancer medicine
10/24/2001	CN1073414C Anaesthetic
10/24/2001	CN1073413C Transdermal therapeutic system and its prep.
10/23/2001	US6307092 Potent ocular hypotensives and are particularly suited for the management of glaucoma.
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307080 Water-soluble zinc pyruvates or their hydrates, method for the product ion thereof and their use
10/23/2001	US6307075 Therapeutically effective 1α, 25-dihydroxyvitamin D3 analogs
10/23/2001	US6307070 Fungicides
10/23/2001	US6307068 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
10/23/2001	US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001	US6307060 Antispasmodic agents
10/23/2001	US6307059 Preparation of quinolone antibiotics.
10/23/2001	US6307056 Inhibit or modulate protein kinases, in particular jnk protein kinases.
10/23/2001	US6307051 2-alkylidene hydroxycoumaranone derivatives
10/23/2001	US6307050 Method of synthesizing flosequinan from 4-fluoroanthranilic acid
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307044 Process for the preparation of macrocyclic metalloprotease inhibitors
10/23/2001	US6307043 For treatment or prophylaxis of herpes viral infections
10/23/2001	US6307032 With von willebrand factor, comprising contacting composition with an immunoaffinity chromatography material, eluting complex with first elution buffer, eluting non-complexed factor viii or von willebrand factor with second buffer
10/23/2001	US6307022 Def
10/23/2001	US6306993 Method and composition for enhancing transport across biological membranes
10/23/2001	US6306915 Oligosaccharides of uronic acid, glucosamine, galactose, and mannose, or one uronic acid; r.sub.2 is an alkyl group, emulsifier of the present invention has marked moisturizing effect, skin roughening preventing effect
10/23/2001	US6306914 Progestin therapy for maintaining amenorrhea
10/23/2001	US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001	US6306911 Enzyme inhibitors
10/23/2001	US6306910 Use of Gaba-analogues for treating insomnia
10/23/2001	US6306909 Anti-epileptogenic agents
10/23/2001	US6306908 Proteins, carbohydrates and lipids
10/23/2001	US6306907 Antipsychotic
10/23/2001	US6306904 Antihistaminic/antitussive compositions
10/23/2001	US6306903 Alpha-aminoamide derivatives useful as analgesic agents
10/23/2001	US6306902 Oxaliplatin formulations
10/23/2001	US6306901 Agent for prophylaxis and therapy of diseases
10/23/2001	US6306900 Enteric coated pharmaceutical compositions
10/23/2001	US6306899 Viricides
10/23/2001	US6306898 Mixture of vitamin e and squalane for skin disorders
10/23/2001	US6306897 Calanolides for inhibiting BTK
10/23/2001	US6306896 Pharmaceutically active composition containing artemisinine and/or derivative of artemisinine
10/23/2001	US6306895 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
10/23/2001	US6306894 Seals on containers for piclitaxel and sealed containers and drugs
10/23/2001	US6306891 Inhibitors of hiv integrase and inhibitors of hiv replication. these compounds are useful in the prevention or treatment of infection by hiv treatment of aids, either as compounds, pharmaceutically acceptable salts
10/23/2001	US6306890 Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors
10/23/2001	US6306889 Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306886 Solid polymorph anticoagulants
10/23/2001	US6306883 Compounds
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306880 Triazole antifungal agent

1 ... 5985 5986 5987 5988 5989 5990 5991 5992 5993 5994 5995 5996 5997 5998 5999 6000 6001 6002 6003 6004 6005 ... 7860